| 0 |
LYMPHOID TISSUE HYPOPLASIA |
143 |
0.9346 |
| 1 |
THYMUS HYPOPLASIA |
144 |
0.8276 |
| 2 |
HUMAN BOCAVIRUS INFECTION |
117 |
0.6190 |
| 3 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
1305 |
0.5913 |
| 4 |
CYSTITIS VIRAL |
180 |
0.4700 |
| 5 |
MANTLE CELL LYMPHOMA RECURRENT |
191 |
0.4391 |
| 6 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
408 |
0.4308 |
| 7 |
B-CELL LYMPHOMA RECURRENT |
231 |
0.4254 |
| 8 |
BLOOD STEM CELL TRANSPLANT FAILURE |
90 |
0.4186 |
| 9 |
VIRAL HAEMORRHAGIC CYSTITIS |
294 |
0.4129 |
| 10 |
ENGRAFTMENT SYNDROME |
237 |
0.4010 |
| 11 |
PRIMARY AMYLOIDOSIS |
94 |
0.3658 |
| 12 |
ENCEPHALITIS CYTOMEGALOVIRUS |
159 |
0.3630 |
| 13 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
893 |
0.3227 |
| 14 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1398 |
0.3161 |
| 15 |
ACUTE GRAFT VERSUS HOST DISEASE |
1438 |
0.3138 |
| 16 |
ENGRAFT FAILURE |
88 |
0.3066 |
| 17 |
FOLLICULAR LYMPHOMA |
265 |
0.3011 |
| 18 |
CYSTITIS BACTERIAL |
100 |
0.2959 |
| 19 |
CONGENITAL APLASIA |
92 |
0.2958 |
| 20 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
97 |
0.2957 |
| 21 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1057 |
0.2925 |
| 22 |
CYSTITIS HAEMORRHAGIC |
1160 |
0.2875 |
| 23 |
VENOOCCLUSIVE DISEASE |
713 |
0.2845 |
| 24 |
NOROVIRUS TEST POSITIVE |
90 |
0.2769 |
| 25 |
DISSEMINATED ASPERGILLOSIS |
127 |
0.2691 |
| 26 |
OVARIAN FAILURE |
143 |
0.2673 |
| 27 |
LYMPHOMA TRANSFORMATION |
95 |
0.2639 |
| 28 |
VENOOCCLUSIVE LIVER DISEASE |
1288 |
0.2606 |
| 29 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
183 |
0.2545 |
| 30 |
HUMAN HERPESVIRUS 6 INFECTION |
481 |
0.2542 |
| 31 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
357 |
0.2527 |
| 32 |
HEPATITIS B REACTIVATION |
797 |
0.2509 |
| 33 |
HUMAN POLYOMAVIRUS INFECTION |
133 |
0.2505 |
| 34 |
SECONDARY IMMUNODEFICIENCY |
303 |
0.2494 |
| 35 |
BK VIRUS INFECTION |
840 |
0.2488 |
| 36 |
GRAFT VERSUS HOST DISEASE IN SKIN |
547 |
0.2481 |
| 37 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
221 |
0.2387 |
| 38 |
B-CELL TYPE ACUTE LEUKAEMIA |
170 |
0.2316 |
| 39 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
305 |
0.2316 |
| 40 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
485 |
0.2277 |
| 41 |
NEUROBLASTOMA |
87 |
0.2272 |
| 42 |
HYPOGAMMAGLOBULINAEMIA |
1472 |
0.2238 |
| 43 |
FEBRILE NEUTROPENIA |
14787 |
0.2227 |
| 44 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1717 |
0.2226 |
| 45 |
CYTOMEGALOVIRUS CHORIORETINITIS |
433 |
0.2218 |
| 46 |
EPSTEIN-BARR VIRAEMIA |
244 |
0.2200 |
| 47 |
PLASMA CELL MYELOMA REFRACTORY |
294 |
0.2197 |
| 48 |
ADENOVIRUS INFECTION |
622 |
0.2143 |
| 49 |
FEBRILE BONE MARROW APLASIA |
887 |
0.2085 |
| 50 |
NEUTROPENIC INFECTION |
193 |
0.2017 |
| 51 |
PREMATURE MENOPAUSE |
185 |
0.2002 |
| 52 |
GRAFT VERSUS HOST DISEASE IN LIVER |
143 |
0.1997 |
| 53 |
CYTOKINE RELEASE SYNDROME |
3893 |
0.1939 |
| 54 |
MYELOID LEUKAEMIA |
97 |
0.1936 |
| 55 |
PSEUDOMONAL SEPSIS |
338 |
0.1928 |
| 56 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
261 |
0.1893 |
| 57 |
GRAFT VERSUS HOST DISEASE |
1354 |
0.1881 |
| 58 |
SYSTEMIC MYCOSIS |
218 |
0.1866 |
| 59 |
PARAINFLUENZAE VIRUS INFECTION |
282 |
0.1852 |
| 60 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
190 |
0.1848 |
| 61 |
JC VIRUS INFECTION |
292 |
0.1825 |
| 62 |
PLASMA CELL LEUKAEMIA |
109 |
0.1817 |
| 63 |
FUSARIUM INFECTION |
126 |
0.1800 |
| 64 |
ENTEROCOCCAL BACTERAEMIA |
187 |
0.1764 |
| 65 |
MYCOBACTERIUM CHELONAE INFECTION |
130 |
0.1759 |
| 66 |
CYTOMEGALOVIRUS VIRAEMIA |
778 |
0.1747 |
| 67 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1034 |
0.1744 |
| 68 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
103 |
0.1737 |
| 69 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
302 |
0.1707 |
| 70 |
NEUTROPENIC SEPSIS |
1219 |
0.1705 |
| 71 |
PNEUMONIA CYTOMEGALOVIRAL |
331 |
0.1703 |
| 72 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
439 |
0.1700 |
| 73 |
HAEMATOTOXICITY |
1616 |
0.1699 |
| 74 |
NEUTROPENIC COLITIS |
344 |
0.1662 |
| 75 |
KLEBSIELLA SEPSIS |
187 |
0.1659 |
| 76 |
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT |
115 |
0.1650 |
| 77 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
836 |
0.1641 |
| 78 |
MENINGITIS TUBERCULOUS |
91 |
0.1628 |
| 79 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
96 |
0.1624 |
| 80 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
362 |
0.1623 |
| 81 |
MYELODYSPLASTIC SYNDROME |
2336 |
0.1613 |
| 82 |
CEREBRAL TOXOPLASMOSIS |
150 |
0.1606 |
| 83 |
PSEUDOMONAL BACTERAEMIA |
137 |
0.1604 |
| 84 |
SECOND PRIMARY MALIGNANCY |
1297 |
0.1558 |
| 85 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
144 |
0.1557 |
| 86 |
INFECTION REACTIVATION |
173 |
0.1511 |
| 87 |
TRANSPLANT FAILURE |
369 |
0.1504 |
| 88 |
ACUTE MYELOID LEUKAEMIA |
2342 |
0.1501 |
| 89 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
1228 |
0.1488 |
| 90 |
HEPATITIS B |
876 |
0.1452 |
| 91 |
VIRAEMIA |
201 |
0.1450 |
| 92 |
APLASIA |
284 |
0.1449 |
| 93 |
TUMOUR LYSIS SYNDROME |
1264 |
0.1435 |
| 94 |
CYTOMEGALOVIRUS INFECTION |
2335 |
0.1403 |
| 95 |
GLIOMA |
90 |
0.1400 |
| 96 |
MUCOSAL INFLAMMATION |
3668 |
0.1400 |
| 97 |
EPSTEIN-BARR VIRUS INFECTION |
875 |
0.1399 |
| 98 |
CARDIOTOXICITY |
1248 |
0.1398 |
| 99 |
BRONCHOPULMONARY ASPERGILLOSIS |
1071 |
0.1380 |
| 100 |
TOXOPLASMOSIS |
148 |
0.1370 |
| 101 |
ENTEROBACTER INFECTION |
229 |
0.1361 |
| 102 |
ENTEROCOCCAL SEPSIS |
110 |
0.1358 |
| 103 |
STEM CELL TRANSPLANT |
339 |
0.1355 |
| 104 |
KLEBSIELLA BACTERAEMIA |
128 |
0.1347 |
| 105 |
POLYOMAVIRUS VIRAEMIA |
142 |
0.1337 |
| 106 |
VARICELLA ZOSTER VIRUS INFECTION |
277 |
0.1335 |
| 107 |
PNEUMOCYSTIS JIROVECII INFECTION |
159 |
0.1331 |
| 108 |
CYTOPENIA |
1613 |
0.1316 |
| 109 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
90 |
0.1310 |
| 110 |
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME |
101 |
0.1292 |
| 111 |
SCEDOSPORIUM INFECTION |
91 |
0.1289 |
| 112 |
LEUKAEMIA RECURRENT |
218 |
0.1288 |
| 113 |
DIFFUSE ALVEOLAR DAMAGE |
148 |
0.1287 |
| 114 |
SYSTEMIC CANDIDA |
323 |
0.1285 |
| 115 |
ASPERGILLUS INFECTION |
837 |
0.1274 |
| 116 |
PERIPHERAL MOTOR NEUROPATHY |
178 |
0.1270 |
| 117 |
MYELOSUPPRESSION |
4509 |
0.1251 |
| 118 |
OBLITERATIVE BRONCHIOLITIS |
164 |
0.1249 |
| 119 |
CANDIDA SEPSIS |
112 |
0.1249 |
| 120 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
351 |
0.1239 |
| 121 |
GRANULOCYTE COUNT DECREASED |
228 |
0.1228 |
| 122 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1234 |
0.1228 |
| 123 |
BACTERIAL SEPSIS |
394 |
0.1209 |
| 124 |
LUPUS NEPHRITIS |
222 |
0.1186 |
| 125 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
98 |
0.1163 |
| 126 |
ESCHERICHIA BACTERAEMIA |
272 |
0.1156 |
| 127 |
STENOTROPHOMONAS INFECTION |
156 |
0.1150 |
| 128 |
STREPTOCOCCAL BACTERAEMIA |
125 |
0.1149 |
| 129 |
PNEUMONIA FUNGAL |
453 |
0.1147 |
| 130 |
MUCORMYCOSIS |
298 |
0.1146 |
| 131 |
MANTLE CELL LYMPHOMA |
174 |
0.1142 |
| 132 |
DILATED CARDIOMYOPATHY |
113 |
0.1118 |
| 133 |
ENCEPHALITIS VIRAL |
136 |
0.1117 |
| 134 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
92 |
0.1111 |
| 135 |
KLEBSIELLA INFECTION |
561 |
0.1108 |
| 136 |
PLASMACYTOMA |
206 |
0.1106 |
| 137 |
FEBRILE INFECTION |
130 |
0.1105 |
| 138 |
IMMUNE-MEDIATED ADRENAL INSUFFICIENCY |
88 |
0.1104 |
| 139 |
ESCHERICHIA SEPSIS |
320 |
0.1103 |
| 140 |
ENTEROCOCCAL INFECTION |
533 |
0.1102 |
| 141 |
HYPOFIBRINOGENAEMIA |
108 |
0.1089 |
| 142 |
CYTOMEGALOVIRUS TEST POSITIVE |
194 |
0.1087 |
| 143 |
THERAPY PARTIAL RESPONDER |
1689 |
0.1082 |
| 144 |
FUNGAEMIA |
170 |
0.1079 |
| 145 |
CYTOGENETIC ABNORMALITY |
121 |
0.1072 |
| 146 |
BONE MARROW TOXICITY |
127 |
0.1072 |
| 147 |
STRONGYLOIDIASIS |
173 |
0.1070 |
| 148 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
801 |
0.1066 |
| 149 |
STAPHYLOCOCCAL BACTERAEMIA |
460 |
0.1057 |
| 150 |
BONE MARROW FAILURE |
2127 |
0.1046 |
| 151 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
997 |
0.1043 |
| 152 |
SUBCLAVIAN VEIN THROMBOSIS |
118 |
0.1036 |
| 153 |
DEVICE RELATED THROMBOSIS |
102 |
0.1034 |
| 154 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
222 |
0.1033 |
| 155 |
PLASMA CELL MYELOMA RECURRENT |
335 |
0.1030 |
| 156 |
ENTEROVIRUS INFECTION |
89 |
0.1030 |
| 157 |
ASPERGILLOSIS |
134 |
0.1025 |
| 158 |
HEPATITIS E |
161 |
0.1019 |
| 159 |
PERIPHERAL SENSORY NEUROPATHY |
594 |
0.1015 |
| 160 |
MICROANGIOPATHY |
95 |
0.1011 |
| 161 |
CAPILLARY LEAK SYNDROME |
208 |
0.1005 |
| 162 |
THROMBOTIC MICROANGIOPATHY |
975 |
0.0999 |
| 163 |
HISTIOCYTOSIS HAEMATOPHAGIC |
292 |
0.0983 |
| 164 |
MYELOPATHY |
182 |
0.0957 |
| 165 |
B-LYMPHOCYTE COUNT DECREASED |
130 |
0.0954 |
| 166 |
B-CELL LYMPHOMA |
321 |
0.0944 |
| 167 |
LYMPHOPENIA |
1336 |
0.0944 |
| 168 |
BLOOD FIBRINOGEN DECREASED |
107 |
0.0937 |
| 169 |
NEOPLASM RECURRENCE |
318 |
0.0937 |
| 170 |
GRANULOMATOSIS WITH POLYANGIITIS |
112 |
0.0928 |
| 171 |
T-CELL LYMPHOMA |
106 |
0.0925 |
| 172 |
STAPHYLOCOCCAL SEPSIS |
456 |
0.0923 |
| 173 |
ENTEROCOLITIS INFECTIOUS |
85 |
0.0921 |
| 174 |
PNEUMATOSIS INTESTINALIS |
261 |
0.0914 |
| 175 |
GENE MUTATION |
181 |
0.0914 |
| 176 |
RHINOVIRUS INFECTION |
354 |
0.0909 |
| 177 |
PNEUMOMEDIASTINUM |
162 |
0.0896 |
| 178 |
ACQUIRED HAEMOPHILIA |
87 |
0.0868 |
| 179 |
LEFT VENTRICULAR DYSFUNCTION |
577 |
0.0861 |
| 180 |
CYTOMEGALOVIRUS COLITIS |
197 |
0.0856 |
| 181 |
CLOSTRIDIUM DIFFICILE COLITIS |
906 |
0.0854 |
| 182 |
ACQUIRED GENE MUTATION |
111 |
0.0847 |
| 183 |
BRAIN ABSCESS |
212 |
0.0837 |
| 184 |
LYMPHOPROLIFERATIVE DISORDER |
246 |
0.0837 |
| 185 |
BACTERAEMIA |
987 |
0.0831 |
| 186 |
PNEUMONIA KLEBSIELLA |
152 |
0.0826 |
| 187 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
103 |
0.0819 |
| 188 |
NEUROTOXICITY |
1426 |
0.0813 |
| 189 |
APLASTIC ANAEMIA |
425 |
0.0813 |
| 190 |
LEUKOENCEPHALOPATHY |
300 |
0.0805 |
| 191 |
ACINETOBACTER INFECTION |
87 |
0.0795 |
| 192 |
GASTROINTESTINAL TOXICITY |
381 |
0.0792 |
| 193 |
NEUTROPENIA |
10780 |
0.0792 |
| 194 |
PANCYTOPENIA |
4426 |
0.0791 |
| 195 |
BLOOD CULTURE POSITIVE |
236 |
0.0787 |
| 196 |
PSEUDOMONAS INFECTION |
675 |
0.0786 |
| 197 |
NOCARDIOSIS |
201 |
0.0785 |
| 198 |
HERPES SIMPLEX |
508 |
0.0781 |
| 199 |
STEROID DIABETES |
117 |
0.0779 |
| 200 |
CLOSTRIDIUM COLITIS |
94 |
0.0774 |
| 201 |
NEUTROPHIL COUNT DECREASED |
3113 |
0.0763 |
| 202 |
MENINGITIS CRYPTOCOCCAL |
133 |
0.0760 |
| 203 |
SOFT TISSUE INFECTION |
139 |
0.0759 |
| 204 |
RENAL TUBULAR INJURY |
92 |
0.0757 |
| 205 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
106 |
0.0754 |
| 206 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
252 |
0.0734 |
| 207 |
SEPTIC SHOCK |
3164 |
0.0726 |
| 208 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
168 |
0.0716 |
| 209 |
OSTEOLYSIS |
143 |
0.0699 |
| 210 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1980 |
0.0698 |
| 211 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1105 |
0.0697 |
| 212 |
DISEASE PROGRESSION |
8229 |
0.0695 |
| 213 |
BREAST CANCER RECURRENT |
219 |
0.0693 |
| 214 |
VENTRICULAR HYPOKINESIA |
222 |
0.0691 |
| 215 |
JUGULAR VEIN THROMBOSIS |
122 |
0.0685 |
| 216 |
TRANSPLANT DYSFUNCTION |
121 |
0.0677 |
| 217 |
POLYNEUROPATHY |
808 |
0.0674 |
| 218 |
PNEUMONIA PSEUDOMONAL |
103 |
0.0671 |
| 219 |
OTOTOXICITY |
124 |
0.0670 |
| 220 |
CARDIAC DYSFUNCTION |
249 |
0.0668 |
| 221 |
PLASMA CELL MYELOMA |
2602 |
0.0666 |
| 222 |
AGRANULOCYTOSIS |
1239 |
0.0666 |
| 223 |
BONE MARROW DISORDER |
201 |
0.0665 |
| 224 |
AMYLOIDOSIS |
113 |
0.0655 |
| 225 |
DEVICE RELATED SEPSIS |
131 |
0.0650 |
| 226 |
VENOUS THROMBOSIS |
253 |
0.0644 |
| 227 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
159 |
0.0643 |
| 228 |
GASTROENTERITIS NOROVIRUS |
85 |
0.0640 |
| 229 |
METASTASES TO MENINGES |
145 |
0.0637 |
| 230 |
LEUKOPENIA |
3157 |
0.0631 |
| 231 |
EJECTION FRACTION DECREASED |
976 |
0.0627 |
| 232 |
OESOPHAGEAL CANDIDIASIS |
250 |
0.0627 |
| 233 |
OPPORTUNISTIC INFECTION |
115 |
0.0621 |
| 234 |
PNEUMONIA PNEUMOCOCCAL |
92 |
0.0621 |
| 235 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
164 |
0.0616 |
| 236 |
VACCINATION FAILURE |
101 |
0.0607 |
| 237 |
NEUTROPHIL COUNT ABNORMAL |
171 |
0.0604 |
| 238 |
HYPOALBUMINAEMIA |
467 |
0.0600 |
| 239 |
MYELITIS |
93 |
0.0600 |
| 240 |
ORGANISING PNEUMONIA |
297 |
0.0599 |
| 241 |
THROMBOCYTOPENIA |
6679 |
0.0597 |
| 242 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
283 |
0.0596 |
| 243 |
PARAPARESIS |
106 |
0.0595 |
| 244 |
CARDIOMYOPATHY |
875 |
0.0591 |
| 245 |
PULMONARY ALVEOLAR HAEMORRHAGE |
329 |
0.0586 |
| 246 |
NEPHROPATHY TOXIC |
655 |
0.0583 |
| 247 |
SKIN TOXICITY |
329 |
0.0582 |
| 248 |
LYMPHOCYTE COUNT DECREASED |
1027 |
0.0580 |
| 249 |
CRYPTOCOCCOSIS |
93 |
0.0570 |
| 250 |
HYPOPROTEINAEMIA |
108 |
0.0569 |
| 251 |
LUNG INFILTRATION |
495 |
0.0560 |
| 252 |
ACUTE LEUKAEMIA |
90 |
0.0557 |
| 253 |
HEPATOSPLENOMEGALY |
143 |
0.0557 |
| 254 |
LUNG CONSOLIDATION |
155 |
0.0554 |
| 255 |
BONE MARROW TRANSPLANT |
105 |
0.0553 |
| 256 |
EMPYEMA |
110 |
0.0553 |
| 257 |
PULMONARY TOXICITY |
391 |
0.0552 |
| 258 |
BACTERIAL INFECTION |
1031 |
0.0552 |
| 259 |
INVASIVE DUCTAL BREAST CARCINOMA |
149 |
0.0548 |
| 260 |
ESCHERICHIA INFECTION |
449 |
0.0545 |
| 261 |
SMALL INTESTINAL PERFORATION |
102 |
0.0543 |
| 262 |
BLOOD IMMUNOGLOBULIN G DECREASED |
134 |
0.0540 |
| 263 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
204 |
0.0533 |
| 264 |
VENTRICULAR DYSFUNCTION |
136 |
0.0524 |
| 265 |
VENA CAVA THROMBOSIS |
87 |
0.0523 |
| 266 |
ENCEPHALITIS |
362 |
0.0523 |
| 267 |
PNEUMONIA VIRAL |
166 |
0.0520 |
| 268 |
SEPSIS |
5803 |
0.0520 |
| 269 |
LYMPHOCYTOSIS |
110 |
0.0511 |
| 270 |
CONGESTIVE CARDIOMYOPATHY |
210 |
0.0503 |
| 271 |
LYMPHOMA |
778 |
0.0503 |
| 272 |
MULTIPLE-DRUG RESISTANCE |
156 |
0.0503 |
| 273 |
METASTASIS |
359 |
0.0502 |
| 274 |
COVID-19 PNEUMONIA |
592 |
0.0501 |
| 275 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
881 |
0.0498 |
| 276 |
HYPERBILIRUBINAEMIA |
513 |
0.0495 |
| 277 |
NEUROLOGICAL DECOMPENSATION |
114 |
0.0492 |
| 278 |
PULMONARY HAEMORRHAGE |
382 |
0.0488 |
| 279 |
PSYCHOLOGICAL TRAUMA |
421 |
0.0487 |
| 280 |
TRAUMATIC LUNG INJURY |
93 |
0.0481 |
| 281 |
LYMPHADENOPATHY MEDIASTINAL |
92 |
0.0480 |
| 282 |
METASTASES TO LYMPH NODES |
318 |
0.0471 |
| 283 |
NEOPLASM PROGRESSION |
1608 |
0.0462 |
| 284 |
PNEUMONIA BACTERIAL |
418 |
0.0455 |
| 285 |
HYPERTRIGLYCERIDAEMIA |
263 |
0.0449 |
| 286 |
CANDIDA INFECTION |
744 |
0.0440 |
| 287 |
ILEUS PARALYTIC |
196 |
0.0439 |
| 288 |
LEFT VENTRICULAR FAILURE |
150 |
0.0435 |
| 289 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
88 |
0.0431 |
| 290 |
HEPATOTOXICITY |
958 |
0.0430 |
| 291 |
GRANULOCYTOPENIA |
245 |
0.0430 |
| 292 |
BONE LESION |
155 |
0.0429 |
| 293 |
RESPIRATORY FAILURE |
3102 |
0.0425 |
| 294 |
DIASTOLIC DYSFUNCTION |
131 |
0.0424 |
| 295 |
ENTERITIS |
271 |
0.0423 |
| 296 |
ESCHERICHIA URINARY TRACT INFECTION |
180 |
0.0423 |
| 297 |
PNEUMONITIS |
1144 |
0.0420 |
| 298 |
RECURRENT CANCER |
171 |
0.0419 |
| 299 |
STAPHYLOCOCCUS TEST POSITIVE |
88 |
0.0417 |
| 300 |
RESPIRATORY SYMPTOM |
118 |
0.0414 |
| 301 |
CUSHINGOID |
133 |
0.0414 |
| 302 |
HYPERPYREXIA |
175 |
0.0413 |
| 303 |
HAEMATOLOGICAL INFECTION |
101 |
0.0413 |
| 304 |
SQUAMOUS CELL CARCINOMA OF SKIN |
249 |
0.0412 |
| 305 |
BREAST CANCER METASTATIC |
440 |
0.0409 |
| 306 |
CLOSTRIDIUM TEST POSITIVE |
90 |
0.0408 |
| 307 |
HYPERTRANSAMINASAEMIA |
283 |
0.0406 |
| 308 |
EMBOLISM |
334 |
0.0402 |
| 309 |
HYPERURICAEMIA |
164 |
0.0399 |
| 310 |
WHITE BLOOD CELL COUNT DECREASED |
4296 |
0.0396 |
| 311 |
GROWTH RETARDATION |
116 |
0.0394 |
| 312 |
MULTI-ORGAN FAILURE |
681 |
0.0394 |
| 313 |
DISSEMINATED INTRAVASCULAR COAGULATION |
554 |
0.0393 |
| 314 |
CLOSTRIDIAL INFECTION |
133 |
0.0393 |
| 315 |
GUILLAIN-BARRE SYNDROME |
189 |
0.0390 |
| 316 |
VARICELLA |
93 |
0.0389 |
| 317 |
METASTASES TO BONE |
639 |
0.0389 |
| 318 |
DERMATOMYOSITIS |
98 |
0.0386 |
| 319 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
395 |
0.0384 |
| 320 |
GASTROINTESTINAL NECROSIS |
112 |
0.0384 |
| 321 |
HYPOPHOSPHATAEMIA |
283 |
0.0383 |
| 322 |
GLOMERULONEPHRITIS |
93 |
0.0380 |
| 323 |
CHRONIC SINUSITIS |
142 |
0.0378 |
| 324 |
URINARY TRACT INFECTION BACTERIAL |
95 |
0.0375 |
| 325 |
LUNG OPACITY |
99 |
0.0375 |
| 326 |
APLASIA PURE RED CELL |
129 |
0.0375 |
| 327 |
METASTASES TO LUNG |
432 |
0.0374 |
| 328 |
NEUROPATHY PERIPHERAL |
3554 |
0.0373 |
| 329 |
INTERSTITIAL LUNG DISEASE |
1805 |
0.0372 |
| 330 |
EMBOLISM VENOUS |
113 |
0.0372 |
| 331 |
ENTEROCOLITIS |
215 |
0.0372 |
| 332 |
HAEMOLYTIC URAEMIC SYNDROME |
86 |
0.0371 |
| 333 |
NEPHROTIC SYNDROME |
252 |
0.0367 |
| 334 |
OLIGOHYDRAMNIOS |
122 |
0.0365 |
| 335 |
ATELECTASIS |
353 |
0.0365 |
| 336 |
IMMUNOSUPPRESSION |
321 |
0.0364 |
| 337 |
HAIR DISORDER |
299 |
0.0363 |
| 338 |
LUNG ADENOCARCINOMA |
109 |
0.0362 |
| 339 |
SERUM FERRITIN INCREASED |
191 |
0.0362 |
| 340 |
DEVICE RELATED INFECTION |
557 |
0.0362 |
| 341 |
SPLENOMEGALY |
423 |
0.0361 |
| 342 |
ACUTE HEPATIC FAILURE |
493 |
0.0360 |
| 343 |
IMMUNE THROMBOCYTOPENIA |
165 |
0.0360 |
| 344 |
ACUTE PULMONARY OEDEMA |
202 |
0.0360 |
| 345 |
CANDIDIASIS |
144 |
0.0359 |
| 346 |
PORTAL HYPERTENSION |
110 |
0.0356 |
| 347 |
DISEASE RECURRENCE |
1680 |
0.0353 |
| 348 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
124 |
0.0352 |
| 349 |
SUSPECTED OFF LABEL USE |
158 |
0.0349 |
| 350 |
DRUG RESISTANCE |
896 |
0.0348 |
| 351 |
PLEURITIC PAIN |
96 |
0.0347 |
| 352 |
LYMPHADENOPATHY |
1229 |
0.0347 |
| 353 |
FOETAL GROWTH RESTRICTION |
211 |
0.0347 |
| 354 |
HYPOXIA |
1221 |
0.0346 |
| 355 |
BRAIN HERNIATION |
103 |
0.0344 |
| 356 |
NECROTISING FASCIITIS |
121 |
0.0343 |
| 357 |
CARDIAC FAILURE ACUTE |
227 |
0.0340 |
| 358 |
VASCULAR DEVICE INFECTION |
154 |
0.0339 |
| 359 |
INTESTINAL PERFORATION |
379 |
0.0337 |
| 360 |
ENCEPHALOPATHY |
826 |
0.0336 |
| 361 |
NECROSIS |
186 |
0.0334 |
| 362 |
THERAPY NON-RESPONDER |
1485 |
0.0330 |
| 363 |
ANAEMIA |
6286 |
0.0329 |
| 364 |
INFECTION |
4742 |
0.0327 |
| 365 |
HYPERVOLAEMIA |
161 |
0.0325 |
| 366 |
HEPATIC NECROSIS |
122 |
0.0324 |
| 367 |
PERICARDIAL EFFUSION |
748 |
0.0323 |
| 368 |
LUNG INFECTION |
502 |
0.0323 |
| 369 |
HERPES VIRUS INFECTION |
186 |
0.0323 |
| 370 |
HEPATIC FUNCTION ABNORMAL |
1196 |
0.0320 |
| 371 |
HEPATIC FAILURE |
964 |
0.0319 |
| 372 |
PLEURAL EFFUSION |
1944 |
0.0319 |
| 373 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
278 |
0.0319 |
| 374 |
ASCITES |
934 |
0.0317 |
| 375 |
HEPATITIS FULMINANT |
94 |
0.0316 |
| 376 |
MALIGNANT NEOPLASM PROGRESSION |
3230 |
0.0315 |
| 377 |
METASTASES TO LIVER |
553 |
0.0314 |
| 378 |
ENDOCARDITIS |
161 |
0.0314 |
| 379 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
404 |
0.0313 |
| 380 |
CHRONIC MYELOID LEUKAEMIA |
144 |
0.0312 |
| 381 |
FIBROSIS |
94 |
0.0305 |
| 382 |
ARTHRITIS BACTERIAL |
125 |
0.0304 |
| 383 |
STAPHYLOCOCCAL INFECTION |
1003 |
0.0304 |
| 384 |
PLATELET COUNT DECREASED |
3226 |
0.0302 |
| 385 |
WHITE BLOOD CELL COUNT ABNORMAL |
193 |
0.0302 |
| 386 |
MADAROSIS |
351 |
0.0302 |
| 387 |
GENERALISED OEDEMA |
371 |
0.0299 |
| 388 |
PULMONARY TUBERCULOSIS |
128 |
0.0299 |
| 389 |
HEPATIC LESION |
128 |
0.0296 |
| 390 |
TRANSAMINASES INCREASED |
655 |
0.0294 |
| 391 |
HEPATOMEGALY |
289 |
0.0294 |
| 392 |
MYOCARDITIS |
336 |
0.0293 |
| 393 |
THROMBOPHLEBITIS |
102 |
0.0291 |
| 394 |
HAIR COLOUR CHANGES |
362 |
0.0291 |
| 395 |
RESPIRATORY DISTRESS |
796 |
0.0288 |
| 396 |
FUNGAL INFECTION |
959 |
0.0287 |
| 397 |
PATHOLOGICAL FRACTURE |
146 |
0.0287 |
| 398 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1565 |
0.0285 |
| 399 |
HYPOKALAEMIA |
1301 |
0.0282 |
| 400 |
CACHEXIA |
144 |
0.0280 |
| 401 |
STOMATITIS |
1696 |
0.0279 |
| 402 |
TRANSPLANT REJECTION |
223 |
0.0278 |
| 403 |
NEUROLOGICAL SYMPTOM |
158 |
0.0276 |
| 404 |
BLOOD BILIRUBIN INCREASED |
745 |
0.0276 |
| 405 |
HYDROCEPHALUS |
150 |
0.0275 |
| 406 |
HYDRONEPHROSIS |
206 |
0.0275 |
| 407 |
PYREXIA |
9368 |
0.0270 |
| 408 |
CLOSTRIDIUM DIFFICILE INFECTION |
585 |
0.0268 |
| 409 |
HAIR TEXTURE ABNORMAL |
358 |
0.0267 |
| 410 |
ADRENAL INSUFFICIENCY |
323 |
0.0266 |
| 411 |
VASCULITIS |
310 |
0.0266 |
| 412 |
STREPTOCOCCAL INFECTION |
148 |
0.0266 |
| 413 |
HAEMATOCRIT DECREASED |
527 |
0.0265 |
| 414 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
619 |
0.0265 |
| 415 |
PRODUCT USE IN UNAPPROVED INDICATION |
6563 |
0.0265 |
| 416 |
SINUS TACHYCARDIA |
375 |
0.0264 |
| 417 |
CARDIAC FAILURE |
2118 |
0.0264 |
| 418 |
FACIAL PARESIS |
93 |
0.0263 |
| 419 |
MULTIPLE MYELOMA |
122 |
0.0262 |
| 420 |
DEAFNESS NEUROSENSORY |
86 |
0.0261 |
| 421 |
MENINGITIS |
174 |
0.0260 |
| 422 |
UROSEPSIS |
240 |
0.0260 |
| 423 |
LUNG NEOPLASM |
111 |
0.0260 |
| 424 |
ELECTROLYTE IMBALANCE |
301 |
0.0259 |
| 425 |
CARDIAC TAMPONADE |
123 |
0.0259 |
| 426 |
HAEMODYNAMIC INSTABILITY |
197 |
0.0258 |
| 427 |
C-REACTIVE PROTEIN INCREASED |
940 |
0.0258 |
| 428 |
ILEUS |
321 |
0.0258 |
| 429 |
SQUAMOUS CELL CARCINOMA |
243 |
0.0258 |
| 430 |
CARDIAC FAILURE CHRONIC |
110 |
0.0258 |
| 431 |
HAEMOGLOBIN ABNORMAL |
166 |
0.0258 |
| 432 |
ABDOMINAL ABSCESS |
114 |
0.0258 |
| 433 |
ORAL CANDIDIASIS |
339 |
0.0257 |
| 434 |
HAEMOLYTIC ANAEMIA |
230 |
0.0256 |
| 435 |
ERYSIPELAS |
129 |
0.0256 |
| 436 |
NEOPLASM |
295 |
0.0256 |
| 437 |
CARDIOPULMONARY FAILURE |
99 |
0.0254 |
| 438 |
ACUTE RESPIRATORY FAILURE |
486 |
0.0252 |
| 439 |
HYPOCALCAEMIA |
478 |
0.0252 |
| 440 |
GASTROINTESTINAL PERFORATION |
105 |
0.0252 |
| 441 |
RESPIRATORY TRACT INFECTION |
656 |
0.0252 |
| 442 |
HEPATIC FIBROSIS |
86 |
0.0250 |
| 443 |
PROTEINURIA |
476 |
0.0250 |
| 444 |
COLITIS |
939 |
0.0247 |
| 445 |
OESOPHAGITIS |
269 |
0.0246 |
| 446 |
EXTRAVASATION |
101 |
0.0246 |
| 447 |
SKIN INFECTION |
275 |
0.0245 |
| 448 |
COAGULOPATHY |
406 |
0.0243 |
| 449 |
MYOSITIS |
218 |
0.0243 |
| 450 |
MALNUTRITION |
271 |
0.0242 |
| 451 |
TACHYPNOEA |
327 |
0.0240 |
| 452 |
PAPILLOEDEMA |
108 |
0.0239 |
| 453 |
HAEMOLYSIS |
184 |
0.0238 |
| 454 |
HYPERCALCAEMIA |
292 |
0.0236 |
| 455 |
BRAIN OEDEMA |
297 |
0.0235 |
| 456 |
LOW BIRTH WEIGHT BABY |
185 |
0.0233 |
| 457 |
LARGE INTESTINE PERFORATION |
161 |
0.0232 |
| 458 |
PYELONEPHRITIS |
199 |
0.0229 |
| 459 |
PATHOGEN RESISTANCE |
208 |
0.0228 |
| 460 |
MITRAL VALVE INCOMPETENCE |
257 |
0.0227 |
| 461 |
ALANINE AMINOTRANSFERASE INCREASED |
1394 |
0.0227 |
| 462 |
TROPONIN INCREASED |
172 |
0.0226 |
| 463 |
BRONCHIECTASIS |
152 |
0.0225 |
| 464 |
MENINGITIS ASEPTIC |
101 |
0.0225 |
| 465 |
RENAL CELL CARCINOMA |
110 |
0.0225 |
| 466 |
INTRACRANIAL PRESSURE INCREASED |
124 |
0.0222 |
| 467 |
ODYNOPHAGIA |
132 |
0.0221 |
| 468 |
HAEMORRHAGE INTRACRANIAL |
328 |
0.0219 |
| 469 |
LEUKOCYTOSIS |
396 |
0.0219 |
| 470 |
METABOLIC DISORDER |
127 |
0.0218 |
| 471 |
METASTATIC NEOPLASM |
94 |
0.0218 |
| 472 |
PROCTALGIA |
140 |
0.0218 |
| 473 |
HAEMATURIA |
743 |
0.0217 |
| 474 |
PNEUMOTHORAX |
344 |
0.0217 |
| 475 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
108 |
0.0217 |
| 476 |
RED CELL DISTRIBUTION WIDTH INCREASED |
90 |
0.0216 |
| 477 |
NEUTROPHIL COUNT INCREASED |
221 |
0.0216 |
| 478 |
HEPATIC CYTOLYSIS |
275 |
0.0215 |
| 479 |
BLOOD DISORDER |
172 |
0.0214 |
| 480 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1139 |
0.0214 |
| 481 |
OSTEONECROSIS |
700 |
0.0213 |
| 482 |
HYPOMAGNESAEMIA |
293 |
0.0210 |
| 483 |
HERPES ZOSTER |
1207 |
0.0210 |
| 484 |
PERFORMANCE STATUS DECREASED |
98 |
0.0210 |
| 485 |
STRESS CARDIOMYOPATHY |
122 |
0.0210 |
| 486 |
PNEUMONIA |
6779 |
0.0209 |
| 487 |
OLIGURIA |
129 |
0.0208 |
| 488 |
RETINAL HAEMORRHAGE |
148 |
0.0208 |
| 489 |
HYPERGLYCAEMIA |
752 |
0.0206 |
| 490 |
DRUG TOXICITY |
281 |
0.0206 |
| 491 |
ABDOMINAL TENDERNESS |
102 |
0.0205 |
| 492 |
GASTROINTESTINAL INFLAMMATION |
160 |
0.0204 |
| 493 |
LIVER INJURY |
494 |
0.0201 |
| 494 |
DRUG-INDUCED LIVER INJURY |
629 |
0.0200 |
| 495 |
GASTROINTESTINAL INFECTION |
179 |
0.0199 |
| 496 |
SHOCK HAEMORRHAGIC |
162 |
0.0199 |
| 497 |
ORAL DISORDER |
145 |
0.0198 |
| 498 |
BASAL CELL CARCINOMA |
307 |
0.0197 |
| 499 |
CARDIOGENIC SHOCK |
282 |
0.0196 |
| 500 |
PULMONARY FIBROSIS |
376 |
0.0196 |
| 501 |
LEUKAEMIA |
184 |
0.0195 |
| 502 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
430 |
0.0194 |
| 503 |
INFLAMMATORY MARKER INCREASED |
96 |
0.0193 |
| 504 |
DEEP VEIN THROMBOSIS |
1258 |
0.0193 |
| 505 |
SMALL INTESTINAL OBSTRUCTION |
238 |
0.0193 |
| 506 |
HEPATIC ENCEPHALOPATHY |
180 |
0.0193 |
| 507 |
TRICUSPID VALVE INCOMPETENCE |
153 |
0.0192 |
| 508 |
CEREBRAL ISCHAEMIA |
99 |
0.0192 |
| 509 |
HYPONATRAEMIA |
1083 |
0.0192 |
| 510 |
OFF LABEL USE |
16826 |
0.0192 |
| 511 |
HAEMOGLOBIN DECREASED |
1964 |
0.0191 |
| 512 |
MYOPATHY |
164 |
0.0190 |
| 513 |
VIRAL INFECTION |
631 |
0.0189 |
| 514 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
96 |
0.0189 |
| 515 |
SARCOIDOSIS |
90 |
0.0189 |
| 516 |
ATRIAL FLUTTER |
151 |
0.0189 |
| 517 |
PREMATURE BABY |
567 |
0.0188 |
| 518 |
ACUTE CORONARY SYNDROME |
156 |
0.0188 |
| 519 |
HEMIPARESIS |
319 |
0.0188 |
| 520 |
HYPOVOLAEMIA |
110 |
0.0188 |
| 521 |
TOXIC ENCEPHALOPATHY |
95 |
0.0187 |
| 522 |
CHOLECYSTITIS ACUTE |
106 |
0.0187 |
| 523 |
ACUTE KIDNEY INJURY |
2843 |
0.0186 |
| 524 |
CHOLECYSTITIS |
221 |
0.0185 |
| 525 |
FACIAL PARALYSIS |
157 |
0.0184 |
| 526 |
HEPATITIS |
471 |
0.0184 |
| 527 |
PULMONARY HYPERTENSION |
382 |
0.0183 |
| 528 |
PULMONARY MASS |
273 |
0.0183 |
| 529 |
INTENTIONAL PRODUCT USE ISSUE |
1600 |
0.0182 |
| 530 |
PULMONARY EMBOLISM |
1733 |
0.0182 |
| 531 |
ATAXIA |
216 |
0.0182 |
| 532 |
ANAL ABSCESS |
98 |
0.0182 |
| 533 |
CHOLESTASIS |
349 |
0.0182 |
| 534 |
HYPOVOLAEMIC SHOCK |
87 |
0.0181 |
| 535 |
PLATELET COUNT ABNORMAL |
109 |
0.0180 |
| 536 |
TOXIC EPIDERMAL NECROLYSIS |
272 |
0.0179 |
| 537 |
LYMPHOEDEMA |
123 |
0.0178 |
| 538 |
SKIN NECROSIS |
92 |
0.0177 |
| 539 |
NASAL POLYPS |
87 |
0.0177 |
| 540 |
BLOOD ALBUMIN DECREASED |
140 |
0.0176 |
| 541 |
NERVOUS SYSTEM DISORDER |
550 |
0.0176 |
| 542 |
CORONAVIRUS INFECTION |
116 |
0.0175 |
| 543 |
ANGIOPATHY |
98 |
0.0175 |
| 544 |
BLOOD LACTIC ACID INCREASED |
91 |
0.0173 |
| 545 |
END STAGE RENAL DISEASE |
315 |
0.0173 |
| 546 |
CELLULITIS |
868 |
0.0172 |
| 547 |
PULMONARY ARTERIAL HYPERTENSION |
248 |
0.0171 |
| 548 |
APPENDICITIS |
159 |
0.0170 |
| 549 |
MOUTH ULCERATION |
358 |
0.0170 |
| 550 |
FAILURE TO THRIVE |
88 |
0.0169 |
| 551 |
GASTROENTERITIS |
247 |
0.0169 |
| 552 |
GINGIVITIS |
91 |
0.0169 |
| 553 |
RALES |
97 |
0.0167 |
| 554 |
STATUS EPILEPTICUS |
188 |
0.0166 |
| 555 |
PETECHIAE |
173 |
0.0166 |
| 556 |
HAEMODIALYSIS |
139 |
0.0165 |
| 557 |
SUPRAVENTRICULAR TACHYCARDIA |
158 |
0.0165 |
| 558 |
SUBDURAL HAEMATOMA |
236 |
0.0165 |
| 559 |
TREATMENT FAILURE |
1365 |
0.0165 |
| 560 |
SKIN MASS |
109 |
0.0163 |
| 561 |
PREMATURE DELIVERY |
258 |
0.0162 |
| 562 |
BONE PAIN |
942 |
0.0161 |
| 563 |
RENAL IMPAIRMENT |
1347 |
0.0160 |
| 564 |
RENAL TUBULAR NECROSIS |
156 |
0.0159 |
| 565 |
MASS |
221 |
0.0158 |
| 566 |
IMMUNODEFICIENCY |
235 |
0.0157 |
| 567 |
ACIDOSIS |
120 |
0.0157 |
| 568 |
BODY TEMPERATURE INCREASED |
319 |
0.0156 |
| 569 |
RENAL FAILURE |
2067 |
0.0156 |
| 570 |
HEPATIC STEATOSIS |
289 |
0.0155 |
| 571 |
PURPURA |
136 |
0.0154 |
| 572 |
PULMONARY OEDEMA |
687 |
0.0153 |
| 573 |
PANCREATITIS ACUTE |
341 |
0.0152 |
| 574 |
HEPATOCELLULAR INJURY |
215 |
0.0151 |
| 575 |
MENTAL STATUS CHANGES |
419 |
0.0151 |
| 576 |
ATRIAL FIBRILLATION |
1469 |
0.0151 |
| 577 |
PROTHROMBIN TIME PROLONGED |
90 |
0.0150 |
| 578 |
LUNG DISORDER |
735 |
0.0150 |
| 579 |
RIGHT VENTRICULAR FAILURE |
105 |
0.0150 |
| 580 |
TYPE 1 DIABETES MELLITUS |
90 |
0.0149 |
| 581 |
HEPATITIS CHOLESTATIC |
90 |
0.0149 |
| 582 |
BLOOD URIC ACID INCREASED |
86 |
0.0149 |
| 583 |
EOSINOPHIL COUNT INCREASED |
124 |
0.0149 |
| 584 |
SHOCK |
341 |
0.0148 |
| 585 |
SUDDEN DEATH |
156 |
0.0147 |
| 586 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
366 |
0.0147 |
| 587 |
APHASIA |
442 |
0.0146 |
| 588 |
LIPASE INCREASED |
112 |
0.0146 |
| 589 |
CONCOMITANT DISEASE AGGRAVATED |
90 |
0.0146 |
| 590 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1685 |
0.0145 |
| 591 |
NO THERAPEUTIC RESPONSE |
176 |
0.0144 |
| 592 |
UPPER RESPIRATORY TRACT INFECTION |
666 |
0.0144 |
| 593 |
BLOOD CREATININE INCREASED |
941 |
0.0144 |
| 594 |
COVID-19 |
2526 |
0.0144 |
| 595 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
87 |
0.0143 |
| 596 |
OSTEONECROSIS OF JAW |
352 |
0.0142 |
| 597 |
GENERALISED TONIC-CLONIC SEIZURE |
235 |
0.0142 |
| 598 |
SKIN LESION |
388 |
0.0141 |
| 599 |
HYPOPHAGIA |
361 |
0.0141 |
| 600 |
HYPOTENSION |
2831 |
0.0141 |
| 601 |
ORAL HERPES |
275 |
0.0141 |
| 602 |
CARDIOMEGALY |
173 |
0.0141 |
| 603 |
ANURIA |
121 |
0.0140 |
| 604 |
NAIL DISORDER |
123 |
0.0140 |
| 605 |
CIRCULATORY COLLAPSE |
239 |
0.0140 |
| 606 |
IMPAIRED QUALITY OF LIFE |
201 |
0.0140 |
| 607 |
INFUSION RELATED REACTION |
926 |
0.0140 |
| 608 |
GASTROINTESTINAL DISORDER |
1246 |
0.0139 |
| 609 |
MALIGNANT MELANOMA |
186 |
0.0139 |
| 610 |
TACHYCARDIA |
1233 |
0.0139 |
| 611 |
HYPOTHYROIDISM |
441 |
0.0138 |
| 612 |
RASH MACULO-PAPULAR |
305 |
0.0137 |
| 613 |
PERICARDITIS |
228 |
0.0136 |
| 614 |
TRANSFUSION |
142 |
0.0135 |
| 615 |
RENAL CYST |
107 |
0.0135 |
| 616 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
226 |
0.0134 |
| 617 |
DECUBITUS ULCER |
108 |
0.0132 |
| 618 |
TOXIC SKIN ERUPTION |
132 |
0.0131 |
| 619 |
HYPERTHERMIA |
100 |
0.0131 |
| 620 |
CEREBRAL INFARCTION |
320 |
0.0131 |
| 621 |
SENSORY LOSS |
105 |
0.0130 |
| 622 |
URINE OUTPUT DECREASED |
114 |
0.0130 |
| 623 |
OEDEMA |
705 |
0.0130 |
| 624 |
MYOCARDIAL ISCHAEMIA |
146 |
0.0128 |
| 625 |
TUBULOINTERSTITIAL NEPHRITIS |
239 |
0.0127 |
| 626 |
WHITE BLOOD CELL COUNT INCREASED |
488 |
0.0127 |
| 627 |
NODULE |
165 |
0.0126 |
| 628 |
CENTRAL NERVOUS SYSTEM LESION |
172 |
0.0125 |
| 629 |
LOWER RESPIRATORY TRACT INFECTION |
568 |
0.0125 |
| 630 |
OSTEOMYELITIS |
226 |
0.0125 |
| 631 |
SUBARACHNOID HAEMORRHAGE |
127 |
0.0125 |
| 632 |
LIVER DISORDER |
552 |
0.0124 |
| 633 |
ABSCESS |
198 |
0.0124 |
| 634 |
OBSTRUCTIVE AIRWAYS DISORDER |
138 |
0.0124 |
| 635 |
RENAL FAILURE ACUTE |
521 |
0.0123 |
| 636 |
CEREBRAL HAEMORRHAGE |
437 |
0.0122 |
| 637 |
TOXICITY TO VARIOUS AGENTS |
2050 |
0.0121 |
| 638 |
PULMONARY CONGESTION |
159 |
0.0120 |
| 639 |
HEMIPLEGIA |
100 |
0.0120 |
| 640 |
RESPIRATORY DISORDER |
359 |
0.0120 |
| 641 |
VENTRICULAR EXTRASYSTOLES |
124 |
0.0119 |
| 642 |
CHILLS |
1397 |
0.0119 |
| 643 |
RHINITIS |
96 |
0.0119 |
| 644 |
HEPATITIS C |
143 |
0.0118 |
| 645 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
87 |
0.0118 |
| 646 |
TENDERNESS |
122 |
0.0117 |
| 647 |
PERITONITIS |
242 |
0.0117 |
| 648 |
GASTROINTESTINAL HAEMORRHAGE |
968 |
0.0116 |
| 649 |
RED BLOOD CELL COUNT DECREASED |
331 |
0.0116 |
| 650 |
DRUG INTOLERANCE |
1116 |
0.0115 |
| 651 |
SPINAL COMPRESSION FRACTURE |
95 |
0.0115 |
| 652 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
335 |
0.0114 |
| 653 |
FLUID OVERLOAD |
166 |
0.0114 |
| 654 |
FULL BLOOD COUNT DECREASED |
229 |
0.0114 |
| 655 |
OBESITY |
181 |
0.0113 |
| 656 |
JAUNDICE |
305 |
0.0113 |
| 657 |
ORAL PAIN |
253 |
0.0113 |
| 658 |
PNEUMONIA ASPIRATION |
282 |
0.0113 |
| 659 |
ISCHAEMIC STROKE |
199 |
0.0111 |
| 660 |
PHARYNGITIS |
137 |
0.0110 |
| 661 |
ACUTE MYOCARDIAL INFARCTION |
324 |
0.0110 |
| 662 |
BLOOD UREA INCREASED |
183 |
0.0109 |
| 663 |
ALTERED STATE OF CONSCIOUSNESS |
236 |
0.0109 |
| 664 |
THERAPEUTIC RESPONSE DECREASED |
660 |
0.0109 |
| 665 |
ALOPECIA |
2136 |
0.0109 |
| 666 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
427 |
0.0108 |
| 667 |
ANOREXIA |
139 |
0.0108 |
| 668 |
HYPERKALAEMIA |
378 |
0.0108 |
| 669 |
ORTHOSTATIC HYPOTENSION |
187 |
0.0107 |
| 670 |
ARRHYTHMIA |
505 |
0.0107 |
| 671 |
HAEMOPTYSIS |
297 |
0.0106 |
| 672 |
VOMITING |
5000 |
0.0106 |
| 673 |
HYPOTONIA |
105 |
0.0105 |
| 674 |
CYSTITIS |
330 |
0.0104 |
| 675 |
SKIN HYPERPIGMENTATION |
89 |
0.0103 |
| 676 |
VENTRICULAR FIBRILLATION |
115 |
0.0103 |
| 677 |
DYSPNOEA EXERTIONAL |
387 |
0.0103 |
| 678 |
REBOUND EFFECT |
116 |
0.0103 |
| 679 |
GLOMERULAR FILTRATION RATE DECREASED |
126 |
0.0102 |
| 680 |
CARDIAC ARREST |
846 |
0.0102 |
| 681 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
113 |
0.0102 |
| 682 |
RESPIRATORY RATE INCREASED |
90 |
0.0101 |
| 683 |
HAEMORRHOIDS |
197 |
0.0101 |
| 684 |
PLATELET COUNT INCREASED |
131 |
0.0100 |
| 685 |
ASPIRATION |
110 |
0.0100 |
| 686 |
VENTRICULAR TACHYCARDIA |
165 |
0.0100 |
| 687 |
GASTRIC ULCER |
189 |
0.0099 |
| 688 |
TOOTH ABSCESS |
101 |
0.0099 |
| 689 |
MOTOR DYSFUNCTION |
101 |
0.0099 |
| 690 |
DEAFNESS |
259 |
0.0099 |
| 691 |
SKIN ULCER |
256 |
0.0099 |
| 692 |
SPINAL PAIN |
116 |
0.0099 |
| 693 |
DYSPHAGIA |
939 |
0.0099 |
| 694 |
GRAND MAL CONVULSION |
91 |
0.0098 |
| 695 |
DIARRHOEA HAEMORRHAGIC |
92 |
0.0098 |
| 696 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
699 |
0.0098 |
| 697 |
ABDOMINAL PAIN |
2284 |
0.0098 |
| 698 |
NEPHROPATHY |
91 |
0.0097 |
| 699 |
FLANK PAIN |
91 |
0.0097 |
| 700 |
DEHYDRATION |
1294 |
0.0097 |
| 701 |
EPILEPSY |
296 |
0.0097 |
| 702 |
DELIRIUM |
334 |
0.0096 |
| 703 |
BLOOD SODIUM DECREASED |
181 |
0.0096 |
| 704 |
SENSORY DISTURBANCE |
154 |
0.0096 |
| 705 |
SPUTUM DISCOLOURED |
89 |
0.0094 |
| 706 |
DRUG ERUPTION |
166 |
0.0094 |
| 707 |
ERYTHEMA MULTIFORME |
87 |
0.0093 |
| 708 |
SEIZURE |
1074 |
0.0093 |
| 709 |
DECREASED APPETITE |
2159 |
0.0093 |
| 710 |
DRUG EXPOSURE DURING PREGNANCY |
316 |
0.0093 |
| 711 |
PRODUCTIVE COUGH |
439 |
0.0092 |
| 712 |
HAEMATEMESIS |
232 |
0.0091 |
| 713 |
CARDIAC FAILURE CONGESTIVE |
734 |
0.0091 |
| 714 |
EYELID PTOSIS |
92 |
0.0090 |
| 715 |
GASTRIC HAEMORRHAGE |
104 |
0.0090 |
| 716 |
ABORTION INDUCED |
85 |
0.0090 |
| 717 |
COGNITIVE DISORDER |
421 |
0.0090 |
| 718 |
SYNCOPE |
899 |
0.0090 |
| 719 |
URINARY TRACT INFECTION |
1527 |
0.0089 |
| 720 |
MELAENA |
197 |
0.0089 |
| 721 |
PANCREATITIS |
470 |
0.0089 |
| 722 |
HYPOTHERMIA |
90 |
0.0089 |
| 723 |
GASTRITIS |
232 |
0.0088 |
| 724 |
LIVER FUNCTION TEST ABNORMAL |
255 |
0.0088 |
| 725 |
DYSARTHRIA |
330 |
0.0088 |
| 726 |
EPISTAXIS |
650 |
0.0087 |
| 727 |
AMENORRHOEA |
152 |
0.0087 |
| 728 |
DIARRHOEA |
5568 |
0.0086 |
| 729 |
METABOLIC ACIDOSIS |
272 |
0.0085 |
| 730 |
ASTHENIA |
3190 |
0.0085 |
| 731 |
OEDEMA PERIPHERAL |
1028 |
0.0084 |
| 732 |
CONDITION AGGRAVATED |
2559 |
0.0084 |
| 733 |
ELECTROCARDIOGRAM QT PROLONGED |
302 |
0.0084 |
| 734 |
HYPERTENSION |
1775 |
0.0084 |
| 735 |
HAEMATOMA |
217 |
0.0084 |
| 736 |
BONE DISORDER |
152 |
0.0083 |
| 737 |
MATERNAL EXPOSURE DURING PREGNANCY |
740 |
0.0083 |
| 738 |
BLINDNESS |
337 |
0.0083 |
| 739 |
OSTEOPOROSIS |
338 |
0.0082 |
| 740 |
FOETAL EXPOSURE DURING PREGNANCY |
667 |
0.0082 |
| 741 |
PRODUCT USE ISSUE |
1539 |
0.0082 |
| 742 |
DRUG INEFFECTIVE |
10788 |
0.0082 |
| 743 |
INFLAMMATION |
422 |
0.0082 |
| 744 |
NIGHT SWEATS |
263 |
0.0082 |
| 745 |
CONSTIPATION |
1752 |
0.0080 |
| 746 |
NAUSEA |
6354 |
0.0080 |
| 747 |
CARDIO-RESPIRATORY ARREST |
335 |
0.0080 |
| 748 |
BRADYCARDIA |
424 |
0.0080 |
| 749 |
EOSINOPHILIA |
140 |
0.0080 |
| 750 |
CONJUNCTIVITIS |
148 |
0.0080 |
| 751 |
THROMBOSIS |
639 |
0.0079 |
| 752 |
OXYGEN SATURATION DECREASED |
446 |
0.0079 |
| 753 |
MUSCULAR WEAKNESS |
894 |
0.0079 |
| 754 |
HYPERLIPIDAEMIA |
94 |
0.0079 |
| 755 |
ULCER |
125 |
0.0078 |
| 756 |
HEPATIC CIRRHOSIS |
146 |
0.0078 |
| 757 |
SKIN REACTION |
109 |
0.0077 |
| 758 |
TOOTH INFECTION |
102 |
0.0077 |
| 759 |
BLOOD CALCIUM DECREASED |
87 |
0.0077 |
| 760 |
DYSURIA |
284 |
0.0077 |
| 761 |
PARALYSIS |
110 |
0.0077 |
| 762 |
DERMATITIS |
161 |
0.0077 |
| 763 |
NEURALGIA |
186 |
0.0076 |
| 764 |
PALLOR |
208 |
0.0076 |
| 765 |
DIPLOPIA |
198 |
0.0076 |
| 766 |
MUSCULOSKELETAL CHEST PAIN |
117 |
0.0076 |
| 767 |
TASTE DISORDER |
152 |
0.0075 |
| 768 |
DIVERTICULITIS |
207 |
0.0075 |
| 769 |
HYPERTHYROIDISM |
108 |
0.0075 |
| 770 |
COUGH |
2082 |
0.0074 |
| 771 |
LIVER FUNCTION TEST INCREASED |
159 |
0.0074 |
| 772 |
HEPATIC ENZYME INCREASED |
502 |
0.0074 |
| 773 |
GOUT |
132 |
0.0073 |
| 774 |
DIALYSIS |
104 |
0.0073 |
| 775 |
ILL-DEFINED DISORDER |
441 |
0.0073 |
| 776 |
DRUG LEVEL INCREASED |
120 |
0.0072 |
| 777 |
UNRESPONSIVE TO STIMULI |
186 |
0.0072 |
| 778 |
COLON CANCER |
107 |
0.0072 |
| 779 |
ANAPHYLACTIC REACTION |
396 |
0.0072 |
| 780 |
SKIN DISORDER |
239 |
0.0072 |
| 781 |
PRODUCT PRESCRIBING ISSUE |
155 |
0.0071 |
| 782 |
IMMUNE SYSTEM DISORDER |
92 |
0.0070 |
| 783 |
COMA |
331 |
0.0069 |
| 784 |
CYANOSIS |
109 |
0.0069 |
| 785 |
CONVULSION |
394 |
0.0069 |
| 786 |
URINARY RETENTION |
229 |
0.0069 |
| 787 |
CONFUSIONAL STATE |
1101 |
0.0068 |
| 788 |
DYSPNOEA |
3852 |
0.0068 |
| 789 |
BLOOD POTASSIUM DECREASED |
204 |
0.0068 |
| 790 |
HYPOKINESIA |
97 |
0.0067 |
| 791 |
HAEMORRHAGE |
697 |
0.0067 |
| 792 |
STEVENS-JOHNSON SYNDROME |
147 |
0.0066 |
| 793 |
SARS-COV-2 TEST POSITIVE |
87 |
0.0066 |
| 794 |
DISORIENTATION |
261 |
0.0066 |
| 795 |
FACE OEDEMA |
111 |
0.0066 |
| 796 |
INTESTINAL OBSTRUCTION |
248 |
0.0066 |
| 797 |
BRONCHOSPASM |
93 |
0.0065 |
| 798 |
DRUG INTERACTION |
1023 |
0.0064 |
| 799 |
RENAL DISORDER |
297 |
0.0064 |
| 800 |
LETHARGY |
365 |
0.0063 |
| 801 |
SPINAL FRACTURE |
127 |
0.0063 |
| 802 |
NEOPLASM MALIGNANT |
421 |
0.0063 |
| 803 |
CARDIOVASCULAR DISORDER |
159 |
0.0063 |
| 804 |
PAIN IN JAW |
177 |
0.0062 |
| 805 |
ANGINA PECTORIS |
179 |
0.0062 |
| 806 |
BLOOD COUNT ABNORMAL |
94 |
0.0062 |
| 807 |
OSTEOPENIA |
94 |
0.0062 |
| 808 |
DEATH |
5287 |
0.0061 |
| 809 |
FEEDING DISORDER |
120 |
0.0059 |
| 810 |
CHEST PAIN |
1094 |
0.0059 |
| 811 |
URINARY INCONTINENCE |
173 |
0.0058 |
| 812 |
BLOOD TRIGLYCERIDES INCREASED |
103 |
0.0058 |
| 813 |
CHEST DISCOMFORT |
589 |
0.0057 |
| 814 |
OROPHARYNGEAL PAIN |
531 |
0.0057 |
| 815 |
EXPOSURE DURING PREGNANCY |
355 |
0.0057 |
| 816 |
PARAESTHESIA |
895 |
0.0057 |
| 817 |
RECTAL HAEMORRHAGE |
244 |
0.0057 |
| 818 |
SINUSITIS |
582 |
0.0057 |
| 819 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
146 |
0.0057 |
| 820 |
LACRIMATION INCREASED |
171 |
0.0057 |
| 821 |
DIABETES MELLITUS |
425 |
0.0056 |
| 822 |
VISUAL ACUITY REDUCED |
184 |
0.0055 |
| 823 |
EAR PAIN |
107 |
0.0055 |
| 824 |
FATIGUE |
4284 |
0.0055 |
| 825 |
LUNG NEOPLASM MALIGNANT |
226 |
0.0055 |
| 826 |
LACTIC ACIDOSIS |
178 |
0.0055 |
| 827 |
MYALGIA |
932 |
0.0055 |
| 828 |
CARDIAC DISORDER |
512 |
0.0055 |
| 829 |
BLOOD PRESSURE DECREASED |
362 |
0.0054 |
| 830 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
193 |
0.0054 |
| 831 |
BACK PAIN |
1246 |
0.0054 |
| 832 |
BREAST CANCER |
495 |
0.0053 |
| 833 |
RASH ERYTHEMATOUS |
252 |
0.0053 |
| 834 |
INFLUENZA |
584 |
0.0052 |
| 835 |
RHINORRHOEA |
336 |
0.0052 |
| 836 |
HYPOAESTHESIA |
775 |
0.0052 |
| 837 |
ABDOMINAL DISTENSION |
539 |
0.0052 |
| 838 |
CATARACT |
305 |
0.0051 |
| 839 |
WEIGHT DECREASED |
1426 |
0.0051 |
| 840 |
TOOTHACHE |
91 |
0.0050 |
| 841 |
RASH PAPULAR |
112 |
0.0050 |
| 842 |
BLOOD PRESSURE SYSTOLIC INCREASED |
97 |
0.0050 |
| 843 |
RIB FRACTURE |
101 |
0.0049 |
| 844 |
SLEEP APNOEA SYNDROME |
92 |
0.0048 |
| 845 |
ANAPHYLACTIC SHOCK |
121 |
0.0047 |
| 846 |
RASH |
2044 |
0.0047 |
| 847 |
PRESYNCOPE |
114 |
0.0047 |
| 848 |
TRANSIENT ISCHAEMIC ATTACK |
158 |
0.0047 |
| 849 |
MUSCULOSKELETAL PAIN |
245 |
0.0047 |
| 850 |
BRONCHITIS |
346 |
0.0047 |
| 851 |
CONTRAINDICATED PRODUCT ADMINISTERED |
141 |
0.0047 |
| 852 |
HYPERSENSITIVITY |
863 |
0.0046 |
| 853 |
HAEMATOCHEZIA |
253 |
0.0046 |
| 854 |
IMPAIRED HEALING |
150 |
0.0046 |
| 855 |
POST PROCEDURAL COMPLICATION |
87 |
0.0045 |
| 856 |
DRUG EFFECT INCOMPLETE |
162 |
0.0045 |
| 857 |
CHRONIC KIDNEY DISEASE |
338 |
0.0044 |
| 858 |
WHEEZING |
262 |
0.0044 |
| 859 |
EATING DISORDER |
94 |
0.0044 |
| 860 |
LABORATORY TEST ABNORMAL |
129 |
0.0044 |
| 861 |
INTERNATIONAL NORMALISED RATIO INCREASED |
123 |
0.0043 |
| 862 |
POLLAKIURIA |
179 |
0.0043 |
| 863 |
DISCOMFORT |
261 |
0.0043 |
| 864 |
MENTAL DISORDER |
183 |
0.0042 |
| 865 |
SPEECH DISORDER |
219 |
0.0042 |
| 866 |
CHOLELITHIASIS |
135 |
0.0041 |
| 867 |
RENAL INJURY |
122 |
0.0041 |
| 868 |
LOSS OF CONSCIOUSNESS |
522 |
0.0041 |
| 869 |
ERYTHEMA |
830 |
0.0040 |
| 870 |
ABDOMINAL PAIN LOWER |
102 |
0.0040 |
| 871 |
FLUID RETENTION |
203 |
0.0040 |
| 872 |
DISTURBANCE IN ATTENTION |
215 |
0.0040 |
| 873 |
ADVERSE EVENT |
366 |
0.0040 |
| 874 |
TREMOR |
655 |
0.0039 |
| 875 |
RESPIRATORY ARREST |
106 |
0.0038 |
| 876 |
THROAT TIGHTNESS |
104 |
0.0038 |
| 877 |
HEADACHE |
2407 |
0.0038 |
| 878 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
110 |
0.0038 |
| 879 |
HEART RATE INCREASED |
373 |
0.0038 |
| 880 |
PSYCHOTIC DISORDER |
111 |
0.0038 |
| 881 |
BLISTER |
211 |
0.0038 |
| 882 |
DIABETIC KETOACIDOSIS |
90 |
0.0037 |
| 883 |
NECK PAIN |
205 |
0.0037 |
| 884 |
HYPOGLYCAEMIA |
177 |
0.0036 |
| 885 |
AGITATION |
266 |
0.0036 |
| 886 |
DYSPEPSIA |
351 |
0.0036 |
| 887 |
TINNITUS |
163 |
0.0035 |
| 888 |
MALAISE |
1522 |
0.0035 |
| 889 |
GASTRIC CANCER |
87 |
0.0034 |
| 890 |
SKIN EXFOLIATION |
289 |
0.0034 |
| 891 |
PAIN |
2085 |
0.0034 |
| 892 |
TYPE 2 DIABETES MELLITUS |
113 |
0.0034 |
| 893 |
ARTHRALGIA |
1391 |
0.0033 |
| 894 |
HYPOACUSIS |
144 |
0.0033 |
| 895 |
PAIN IN EXTREMITY |
985 |
0.0033 |
| 896 |
GASTROOESOPHAGEAL REFLUX DISEASE |
268 |
0.0033 |
| 897 |
ABDOMINAL PAIN UPPER |
678 |
0.0033 |
| 898 |
PALPITATIONS |
385 |
0.0033 |
| 899 |
LIMB DISCOMFORT |
101 |
0.0033 |
| 900 |
RHABDOMYOLYSIS |
136 |
0.0033 |
| 901 |
DYSGEUSIA |
242 |
0.0033 |
| 902 |
DYSSTASIA |
95 |
0.0033 |
| 903 |
CEREBROVASCULAR ACCIDENT |
551 |
0.0032 |
| 904 |
SWELLING FACE |
211 |
0.0032 |
| 905 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
169 |
0.0032 |
| 906 |
NASAL CONGESTION |
183 |
0.0031 |
| 907 |
DYSPHONIA |
182 |
0.0031 |
| 908 |
TREATMENT NONCOMPLIANCE |
168 |
0.0031 |
| 909 |
HYPERHIDROSIS |
394 |
0.0031 |
| 910 |
MYOCARDIAL INFARCTION |
533 |
0.0031 |
| 911 |
CORONARY ARTERY DISEASE |
90 |
0.0030 |
| 912 |
DIZZINESS |
1449 |
0.0029 |
| 913 |
RASH PRURITIC |
157 |
0.0029 |
| 914 |
ASTHMA |
324 |
0.0029 |
| 915 |
MOVEMENT DISORDER |
92 |
0.0029 |
| 916 |
PROSTATE CANCER |
230 |
0.0029 |
| 917 |
SLEEP DISORDER |
201 |
0.0028 |
| 918 |
UNEVALUABLE EVENT |
203 |
0.0027 |
| 919 |
VERTIGO |
163 |
0.0027 |
| 920 |
VISUAL IMPAIRMENT |
331 |
0.0027 |
| 921 |
WEIGHT INCREASED |
596 |
0.0027 |
| 922 |
VISION BLURRED |
365 |
0.0027 |
| 923 |
GAIT DISTURBANCE |
506 |
0.0026 |
| 924 |
OSTEOARTHRITIS |
112 |
0.0026 |
| 925 |
INFLUENZA LIKE ILLNESS |
217 |
0.0026 |
| 926 |
SWELLING |
244 |
0.0026 |
| 927 |
SOMNOLENCE |
522 |
0.0026 |
| 928 |
EMOTIONAL DISTRESS |
308 |
0.0025 |
| 929 |
HOT FLUSH |
187 |
0.0025 |
| 930 |
SKIN DISCOLOURATION |
114 |
0.0025 |
| 931 |
INSOMNIA |
659 |
0.0025 |
| 932 |
DEPRESSION |
560 |
0.0025 |
| 933 |
ANXIETY |
698 |
0.0025 |
| 934 |
FALL |
816 |
0.0024 |
| 935 |
MEMORY IMPAIRMENT |
333 |
0.0024 |
| 936 |
ABDOMINAL DISCOMFORT |
404 |
0.0024 |
| 937 |
RESTLESSNESS |
87 |
0.0024 |
| 938 |
ARTHROPATHY |
131 |
0.0024 |
| 939 |
MUSCULOSKELETAL STIFFNESS |
204 |
0.0023 |
| 940 |
ANGIOEDEMA |
102 |
0.0023 |
| 941 |
MOBILITY DECREASED |
165 |
0.0023 |
| 942 |
ARTHRITIS |
180 |
0.0023 |
| 943 |
ADVERSE DRUG REACTION |
203 |
0.0023 |
| 944 |
BLOOD PRESSURE INCREASED |
345 |
0.0023 |
| 945 |
DRY MOUTH |
183 |
0.0023 |
| 946 |
DEPRESSED MOOD |
119 |
0.0022 |
| 947 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
108 |
0.0022 |
| 948 |
PERIPHERAL SWELLING |
344 |
0.0022 |
| 949 |
DRY EYE |
111 |
0.0022 |
| 950 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
99 |
0.0022 |
| 951 |
BALANCE DISORDER |
191 |
0.0022 |
| 952 |
DYSKINESIA |
89 |
0.0022 |
| 953 |
NO ADVERSE EVENT |
393 |
0.0022 |
| 954 |
FLUSHING |
220 |
0.0022 |
| 955 |
ABORTION SPONTANEOUS |
86 |
0.0021 |
| 956 |
MUSCLE SPASMS |
389 |
0.0021 |
| 957 |
PRURITUS |
805 |
0.0021 |
| 958 |
VAGINAL HAEMORRHAGE |
90 |
0.0021 |
| 959 |
NEPHROLITHIASIS |
94 |
0.0020 |
| 960 |
HALLUCINATION |
154 |
0.0020 |
| 961 |
NASOPHARYNGITIS |
372 |
0.0020 |
| 962 |
URTICARIA |
338 |
0.0020 |
| 963 |
JOINT SWELLING |
236 |
0.0020 |
| 964 |
CONTUSION |
181 |
0.0019 |
| 965 |
EYE PAIN |
103 |
0.0018 |
| 966 |
AMNESIA |
118 |
0.0018 |
| 967 |
ILLNESS |
182 |
0.0018 |
| 968 |
ECZEMA |
92 |
0.0018 |
| 969 |
FEELING HOT |
106 |
0.0017 |
| 970 |
UNDERDOSE |
125 |
0.0017 |
| 971 |
RHEUMATOID ARTHRITIS |
193 |
0.0017 |
| 972 |
HOSPITALISATION |
257 |
0.0017 |
| 973 |
MEDICATION ERROR |
91 |
0.0016 |
| 974 |
BLADDER CANCER |
95 |
0.0016 |
| 975 |
BURNING SENSATION |
113 |
0.0016 |
| 976 |
IRRITABILITY |
88 |
0.0015 |
| 977 |
THERAPY INTERRUPTED |
103 |
0.0014 |
| 978 |
BLOOD GLUCOSE INCREASED |
263 |
0.0014 |
| 979 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
240 |
0.0013 |
| 980 |
INJURY |
92 |
0.0013 |
| 981 |
DRY SKIN |
164 |
0.0012 |
| 982 |
OVERDOSE |
250 |
0.0012 |
| 983 |
FEELING ABNORMAL |
262 |
0.0011 |
| 984 |
MIGRAINE |
101 |
0.0011 |
| 985 |
SUICIDAL IDEATION |
89 |
0.0010 |
| 986 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
120 |
0.0006 |
| 987 |
PRODUCT DOSE OMISSION ISSUE |
136 |
0.0005 |
| 988 |
INJECTION SITE PAIN |
89 |
0.0003 |